Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.

Source:http://linkedlifedata.com/resource/pubmed/id/15327516

Download in:

View as

General Info

PMID
15327516